Eastern Kentucky University

Encompass
Online Theses and Dissertations

Student Scholarship

January 2018

Gene Knockout Of PRFA And The Arginine Deiminase Pathway In
Listeria Monocytogenes
Kearstin Edmonds
Eastern Kentucky University

Follow this and additional works at: https://encompass.eku.edu/etd
Part of the Immunology and Infectious Disease Commons, and the Medical Cell Biology Commons

Recommended Citation
Edmonds, Kearstin, "Gene Knockout Of PRFA And The Arginine Deiminase Pathway In Listeria
Monocytogenes" (2018). Online Theses and Dissertations. 523.
https://encompass.eku.edu/etd/523

This Open Access Thesis is brought to you for free and open access by the Student Scholarship at Encompass. It
has been accepted for inclusion in Online Theses and Dissertations by an authorized administrator of Encompass.
For more information, please contact Linda.Sizemore@eku.edu.

GENE KNOCKOUT OF PRFA AND THE ARGININE DEIMINASE PATHWAY IN
LISTERIA MONOCYTOGENES

BY

KEARSTIN L. EDMONDS

THESIS APPROVED:

STATEMENT OF PERMISSION TO USE
In presenting this thesis in partial fulfillment of the requirements for a Masters in Biology
degree at Eastern Kentucky University, I agree that the Library shall make it available to
borrowers under rules of the Library. Brief quotations from this thesis are allowable
without special permission, provided that accurate acknowledgment of the source is
made. Permission for extensive quotation from or reproduction of this thesis may be
granted by my major professor, or in [his/her] absence, by the Head of Interlibrary
Services when, in the opinion of either, the proposed use of the material is for scholarly
purposes. Any copying or use of the material in this thesis for financial gain shall not be
allowed without my written permission.

Signature _____________________________________

April 25,2018
Date __________________________________________

GENE KNOCKOUT OF PRFA AND THE ARGININE DEIMINASE PATHWAY
IN LISTERIA MONOCYTOGENES

BY
KEARSTIN L. EDMONDS

Bachelor of Science
Eastern Kentucky University
Richmond, Kentucky
2013

Submitted to the Faculty of the Graduate School of
Eastern Kentucky University
in partial fulfillment of the requirements
for the degree of
MASTER OF SCIENCE
May, 2018

Copyright © Kearstin L. Edmonds, 2018
All rights reserved

ii

ACKNOWLEDGMENTS

I would like to thank Dr. Marcia Pierce for her assistance, both academically and
personally constructive, throughout the pursuit of my master degree. I would also like to
thank Drs. Rebekah Waikel and William Staddon for their advice and time through the
length of my thesis research. A special thank you to Dr. Sarah D’Orazio from the
University of Kentucky for her assistance through the sharing of her research knowledge
and pKSV7 vector samples. Finally, I would like to thank my mother Tracy L. Epps for
her emotional support through everything in my life, personal and academic.

iii

ABSTRACT

Listeria monocytogenes is a Gram-positive facultative intracellular pathogen. This
species is a common cause of food-borne illness outbreaks with high fatality rates. L.
monocytogenes is known to produce a number of virulence factors, including enzymes
and toxins, that are involved in the disease process. The arginine deiminase pathway has
the ability to regulate acidic environments by converting arginine to ammonia, ornithine,
and ATP. With the help of a membrane-bound antiporter, the ornithine is transported out
of the cell while the ammonia is converted to ammonium. The ATP by-product can also
be used with the F0F1-ATPase system to help maintain homeostasis. The prfA gene,
which codes for the PrfA protein, is considered to be a crucial virulence regulator in L.
monocytogenes. The PrfA protein has the ability to bind to palindromic promoter boxes
within the chromosome in order to recruit necessary components for transcription of ten
crucial virulence factors. This study attempted to produce genetic knockouts of the prfA
gene and ADI pathway. The splicing overlap extension polymerase chain reaction
method was used for genetic manipulation in this study. The 6.9 kb shuttle vector pKSV7
was used to introduce the spliced genetic insert into the wild type strain. The pKSV7-AD
vector for the Δarc was successfully introduced into L. monocytogenes. The integration
of the plasmid into the host chromosome was also successful; however the plasmid did
not integrate with the gene of interest. The attempted Δarc was unsuccessful due to the
inability of the spliced SoeAD-pKSV7 insert to bind to the gene of interest. The pKSV7AD vector for the attempted ΔprfA successfully incorporated into the L. monocytogenes
chromosome. The prfA SoeAD-pKSV7 inserted in the correct gene of interest, resulting
in a successful mutant strain.

Key words: Listeria monocytogenes; transformation; virulence; prfA; arginine
deiminase; SOEing; listerosis; pKSV7, knock-out
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CHAPTER 1
INTRODUCTION

1.1 Listeria monocytogenes background
Listeriosis, a condition caused by L. monocytogenes infection, has been ranked as
the third most fatal food-borne illness in the United States (1). After a series of foodborne illness outbreaks during the 1980s, L. monocytogenes became a widely studied
pathogenic species (2). The disease has a 20-40% fatality rate in humans, which is higher
than most food-borne illnesses (3, 4). As of 2011 in the U.S., L. monocytogenes was the
third most fatal food-borne illness, with a 19% fatality rate (1). The two most fatal foodborne illnesses recorded were Salmonella (28%) and Toxoplasma gondii (24%) (1).
Listeriosis can occur in various mammals, affecting the central nervous system,
bloodstream, or the uterus during pregnancy. Other species of Listeria, L. inovii and L.
seeliger, have been known to cause listeriosis, but this event rarely occurs (2, 5). In most
human cases of infection, individuals are immunocompromised or pregnant (2, 6–8).
Pregnant women infected with the disease usually exhibit mild flu-like symptoms or are
asymptomatic (2). The infected fetus, however, is often lost to miscarriage or born with a
neonatal case of listerosis (2). Patients in the neonatal stage have also been known to
contract the bacterium via cross-contamination (9). Pregnant women make up about 1724% of clinical cases with about 28% of cases resulting in abortion or stillbirth (2).
Human immunodeficiency virus (HIV)-infected individuals have a high infection rate
with L. monocytogenes, due to their immunocompromised state (9). This fact results in
many underprivileged countries with high HIV rates also having elevated listerosis rates
(9).
Human cases are primarily contracted via ingestion, although contact with
infected animals or humans can sometimes result in infection and disease (2). Clinical
presentation of the diseased state varies between 1-90 days post infection, with an
average of 30 days (2, 10). Cases of human infection have a peak season in the fall or late
summer. However, livestock peak season usually occurs in the spring (2). Infection can
1

also occur in livestock, including sheep and goats, and most commonly results in
encephalitis, miscarriage, or septicemia (2). This can result in significant economic loss
due to rapid transmission through livestock. The disease is easily treated with combined
antibiotic therapy. The accepted form of antibiotic therapy is combined treatment with
ampicillin and gentamicin (2). Listeria species show resistance to cephalosporins,
aztreonam, pipemidic acid, and dalfopristin/quinupristin sulfamethoxazole (2).
Although most individual infections with L. monocytogenes are sporadic, there
have been concentrated food-borne outbreaks documented around the world (2, 4, 6, 7).
Many foods have been associated with listerosis outbreaks (Table 1). The infectious dose
of L. monocytogenes is unknown and likely varies among patients (2). The average
contamination level of foods ingested by affected patients is 102-106 CFUs/ml/g (2, 11).
Some countries accept foods containing below 100 CFUs/g (2). The United States,
however, has a no-tolerance policy for the presence of L. monocytogenes in any food (2,
11). Commonly contaminated foods can be seen in Table 1. L. monocytogenes is
ubiquitous in the environment, and contamination can occur in foods grown in soil (7).
Listeria survive as saprophytes in soil, vegetation, and water, and upon ingestion can
move to a replicating phase (2).
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Table 1. Foods associated with L. monocytogenes infections

Dairy

Meats

Fish

Vegetables

Soft Cheese

Cooked Chicken

Shellfish

Coleslaw

Milk

Turkey Frankfurters

Shrimp

Vegetable rennet

Ice Cream

Sausages

Smoked Fish

Salted Mushroom

Butter

Pate and Rillettes

Cod Roe

Alfalfa

Foods that have been correlated with L. monocytogenes contamination and
food-borne illness (2, 4, 6, 12). L.monocytogenes is ubiquitous in the
environment; however most mass outbreaks occur due to contaminated foods.
Source(s): Liu D. 2008. The Handbook of Listeria Monocytogenes. Taylor Fr.
Gr. 6.

1.2 Morphology and physiology
All members of the genus Listeria are Gram-positive rods, with a cell size of
about 0.4-0.5 μm wide by 1-2 μm long (2, 13–15). The cell wall is comprised of a
peptidoglycan multilayer with mesodiaminopimelic acid (meso-DAP), which is typical of
Gram-positive bacteria (8, 16). The ribotol, lipotechoic acids, and flagella antigens
determine the various serotypes of L. monocytogenes (2). The bacteria are motile via 5-6
peritrichous flagella that are uniformly distributed around the cell (2, 7, 16). Motility is
most active between 20-25°C, and lost at 37°C (2). L. monocytogenes is a facultative
anaerobe and a neutrophile (2, 7, 16). Listeria are generally unchallenging to grow as
they only require biotin, thiamine, riboflavin, thioctic acid, and some amino acids (2).
Therefore the species grows well on non-selective media (2). However, it has been shown
that brain-heart infusion broth provides the best nutrients for growth (8, 12, 13, 17, 18).
3

Blood agar plates are the best solid selective medium for the species and help identify
Listeria due to hemolytic virulence factors (2). The production of virulence factor
phospholipase-C creates blue-turquoise colonies on media containing L- α phosphatidylinositol, which is another identifying characteristic of the bacterium (14, 18).
L. monocytogenes has the ability to survive extreme conditions including high pH,
extreme temperatures, and high salt concentrations (4, 6, 8, 12, 18). The bacterium has
efficient stress response mechanisms that allow regulation and survival in extreme
situations (6, 12).
L. monocytogenes is a widely studied bacterial species because of its virulence
capabilities, but not all serotypes express the same virulence (18). Only three serotypes
are associated with human clinical cases: 1/2a, 1/2b, and 4b (19). The French Centre
National de Référence des Listeria explored the infection levels of L. monocytogenes
serotypes between 2001-2003 in human clinical cases by characterizing the serotypes
from multiple sources, and they found that serotype 4b caused 49% of human clinical
cases (2). The 1/2a serotype was the second highest cause of clinical cases at 27% (2).
The Agence Française de Sécurité Sanitaire in Maisons-Alfort, France combined
voluntary submissions of strains isolated from foods to determine percentages of
serotypes. They discovered that the 1/2a strain was the most frequent contaminating
serotype found in foods (64%), and was significantly higher than the second highest
(1/2c) at 12% (2). The 1/2a strain is usually responsible for human clinical cases related
to food-borne illness (19).

1.3 Virulence
Virulence factors are crucial for the ability of L. monocytogenes to proliferate in a
mammalian host (4, 8, 12, 14, 20). When the bacteria are ingested they enter host
immune cells, multiply, and spread to neighboring cells (7, 12, 14). L. monocytogenes has
several virulence factors that allow it to survive environments other species cannot (7,
12). When the host ingests L. monocytogenes, the bacterium moves to hostile pH levels in
4

the stomach, and then to the intestinal lumen (7, 8, 21). Here the bacterium invades
intestinal mucosa by route of M cells within Peyer’s patches and intestinal endothelial
cells (2). The bacteria can multiply there before entering the circulatory system. In the
blood and lymph systems, the bacterium comes into contact with macrophages of the
liver, where most invading cells are destroyed (2, 18). However, those that survive move
to phagocytic cells of the spleen, where they are internalized (2, 21).
Phagocytic cells take in foreign particles and place them in an intracellular
vacuole that will degrade them (2, 12, 14). L. monocytogenes escapes this vacuole and
multiplies in the cytoplasm (2, 6, 7). The bacterial cell induces polymerization of actin,
causing structures known as actin comet tails to form (18). These comet tails are used to
propel the bacterium from the cytoplasm to the cell membrane, where it is propelled out
of the phagocytic cell, while acquiring a portion of the host membrane before entering the
next phagocytic cell (2, 18). As it enters the second phagocytic cell, it is engulfed by an
internal vacoule, resulting in a double membrane surrounding the bacterial cell (6). When
the outer layer of the double membrane is lysed, a new infection cycle will occur. The
ability of L. monocytogenes to evade the immune system results in a disease state in the
host.
There are three important stress factors that L. monocytogenes can withstand:
heat, acid, and osmotic stress (4–6). The ability to withstand these obstacles allows the
bacteria to survive many common food processing measures, which leads to food-borne
outbreaks (2). The virulence factors are particularly important in surviving the host
infection cycle. Heat stress occurs when L. monocytogenes moves from a external
environment into the host body, and again at numerous stages in its infectious cycle (5).
This stress can be regulated by a series of heat-shock proteins (HSPs) that work to re-fold
proteins during heat degradation (8, 14, 21). Unique to L. monocytogenes is its ability to
regulate highly acidic conditions.
The bacterium faces acidic stress due to low pH and weak organic acids in its
surroundings (6, 7). L. monocytogenes, like many other bacteria, is a neutrophile with an
optimum pH of 6 or 7 (2). The species has evolved the ability to regulate pH to maintain
5

stability using a variety of factors (6). L. monocytogenes primarily uses glutamate
decarboxylase, F0F1-ATPase system, and the arginine deiminase pathway (6, 20). The
glutamate decarboxylase (GAD) system works by irreversibly converting a molecule of
external glutamate to γ-aminobutyrate (GABA) (6, 20). This removes some intracellular
protons, helping to maintain pH homeostasis. The F0F1-ATPase system in L.
monocytogenes actively moves protons out of the cell to regulate pH (4–7). The final acid
stress mechanism is the regulation of the arginine deiminase (ADI) system (6). High
levels of arginine are secreted by the host cell into the phagosome where the pathogen is
sequestered (6). This pathway allows the conversion of arginine to ornithine, carbon
dioxide, and ammonia (6, 12, 16, 20, 21). This prevents death of the bacteria in hostile
pH levels because it produces a less acidic environment.

1.4 Arginine deiminase (ADI) pathway molecular background
Three primary molecules are used in the ADI pathway regulation: arginine
deiminase, catabolic ornithine carbamoyltransferase (cOTCase), and carbamate kinase
(CK) (6, 20). For every mole of arginine catabolized by cOTCase, two moles of ammonia
and one mole of ATP are produced (6, 20). These products can combine with intracellular
protons to create ammonium ions, increasing the pH inside the cell (6, 20). The ornithine
that is produced in the pathway is moved out of the cell in an energy-independent
mechanism via a membrane-bound antiporter (6, 20). The ATP produced in the pathway
can be fed into the F0F1-ATPase system, furthering the intracellular pH balance (6, 20).
The genes that control the arginine deiminase pathway are referred to as arc
genes. These genes have a unique arrangement as follows: arcB, arcD, arcC, and arcA
(20). The arcA gene is physically separate from the other arc genes by three
uncategorized genes (20). There are also accessory genes on both sides of the gene
cluster. The precise function of the accessory genes is not known, but research suggests
they aid in pathway regulation (2). A fifth gene, argR, has been associated with
regulation of the pathway by coding for a dual regulator molecule, argR (2). Research
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also suggests another physically separate gene, argG, plays a role in arginine production
and is up-regulated to increase production under stress response (2).
Each of the genes in the arc cluster code for a protein needed in the ADI pathway;
a summary can be seen in Table 2. The arginine deiminase enzyme is encoded by the
arcA gene, catabolyic ornithine carbamoyltransferase (cOTCase) by the arcB gene, and
carbomate kinase (CK) by the arcC gene (20). These three enzymes are the main
components of the arginine deiminase pathway (2, 6, 20, 22). The primary function of
this pathway is to generate resistance to acidic environments. This is achieved, in part, by
converting arginine to ornithine. There are two sources of arginine; the first is naturally
formed within the cell from glutamate, and the second is the arginine:ornithine antiporter
molecule, encoded by the arcD gene (20). This antiporter moves molecules of arginine
into the cell to be catabolized. The arginine deiminase enzyme will catabolize arginine to
citrulline, after which cOTCase will further break down the molecule to produce
ornithine (2, 6, 23). As a byproduct of this process, 2 moles of ammonia are produced
along with carbamoyl-P, which is dephosphorylated by CK to yield one mole of ATP (20,
23). Carbon dioxide is also a byproduct of the catabolic reaction. The ammonia combines
with intracellular hydrogen ions to produce ammonium ions that will increase the pH in
order to maintain homeostasis (2). The ornithine is moved out of the cell using the
antiporter molecule. The ATP can be fed into the F0F1-ATPase system to extrude protons
from the cell in order to regulate homeostasis, or to aid with general microbial growth (2,
20). The dual regulator molecule, argR, aids survival by simultaneously up-regulating
expression of the ADI pathway and down-regulating arginine biosynthesis (20). As
previously mentioned, argG, which aids in arginine synthesis, is up-regulated under
stress response (6). This seems counterproductive; however, research by Ryan et al.
(2009) shows that an argG mutant is actually more sensitive to acid stress (6). This
suggests that both intracellular arginine produced by L. monocytogenes and extracellular
arginine imported to the cell are crucial to acid stress regulation (6).
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Table 2. Arginine deiminase genes

Abbreviation

Encoding Gene

Arginine deiminase

ADI

arcA

Catabolic Ornithine
carbamoyltransferase

cOTCase

arcB

Carbamate kinase

CK

arcC

Arginine:Orinthine Antiporter

-

arcD

The arginine pathway encodes for three enzymes and an antiporter protein. The enzymes work to break
down arginine molecules into ornithine, NH3, ATP, and CO2. The antiporter is an intramembrane
molecule that imports arginine and exports ornithine.

In a study by Ryan et al. (2009), the arginine deiminase pathway (ADI) was
disrupted at different loci for virulence factors. Genes were characterized by inducing
mutant strains that had deficient forms of argD, argG, argA, and argR. The ArgD and
argG mutant cells were starved of arginine, then briefly re-exposed to arginine medium,
before being introduced into epithelial cells (7). The argD mutant had increased acid
sensitivity, but the argG mutant did not show significant change (7). The mutant strains
were then introduced into mice, where it was found that the argA and argR mutants had
10x less survival than the parent strain (7). These results indicate disruption of the overall
virulence of L. monocytogenes. However, when the mutants were introduced in vivo to
epithelial cells, no change in pathogen survival from parent strains was observed (6). This
indicates some other virulence factor must be involved in vivo.
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1.5 The prfA gene and PrfA regulon
Virulence factors are critical to the ability of L. monocytogenes to carry out the
host infection cycle. One particularly important component of this species is the prfA
gene, which codes for the PrfA protein. PrfA is a central virulence regulator used during
every phase of the bacterial life cycle (2, 6, 7, 13, 19). The prfA regulon can act as an
activator or repressor of its own gene cluster as well as controlling transcription of
several other genes (2, 19, 24). The ten core genes subject to PrfA regulation include: hly,
mpl, actA, plcB, plcA, prfA, inlA, inlB, inlC, and hpt (2, 4, 14, 19, 25). When L.
monocytogenes is exposed to high stress environments such as high acidity, host
proteolytic enzymes, bile salts, and non-specific inflammatory attacks, the stress response
genes are turned on by sigma factor beta (σB) (2). This factor is an accessory molecule to
the PrfA protein and is encoded by the sigB gene (2).
The hly gene codes for the hemolysin protein that is the determinant of
listeriolysin O (LLO) (4, 7, 24). LLO is a hemolytic protein that is a part of the
cholesterol dependent pore-forming toxin (CDTX) family (2, 19). Cholesterol is the
receptor for LLO and is required for pore creation. When LLO binds to erythrocytes,
toxin monomers oligomerize in the target cell membrane to form pores (2). Pores are also
formed for escape from the host cell vacuole via lysis during the infection cycle (2, 19).
When cholesterol levels are low, the ability of the protein to function is limited (2, 19).
Studies have shown that mutants lacking the hly gene are entirely avirulent in mouse
models (2).
There are two phospholipases and a metalleoprotease (Mpl) that work with LLO
to disrupt phagosome membranes (2, 7, 12). Phosphatidylinositol-phospholipase C (PIPLC) is an enzyme that hydrolyzes phosphatidylinositol (2, 7, 12). This enzyme is
encoded by the plcA gene, which can be found upstream of the hly gene (2). The
enzymatic activity of this protein aids LLO in the escape from the host vacuole. This
molecule is characterized by a barrel domain with an active site on its c-terminal area (2,
7, 12). The second phospholipase hydrolyzes phosphatidylcholine and is known as
phosphatidylcholine-phospholipase C (PC-PLC) or lecithinase (2, 7, 12). This enzyme is
9

not as substrate-specific as PI-PLC. The gene plcB that codes for this enzyme is
downstream from the hly gene (2). Mpl helps aid in cell-to-cell spread by activating PCPLC with proteolytic activity (2). The PC-PLC relies on this activation by
metalloprotease Mpl, coded by the gene mpl, to function.
A cell-surface protein, actin-polymerization protein (ActA), aids in the
intracellular proliferation of L. monocytogenes and is encoded by the gene actA (7, 12,
14). The primary function of ActA is to induce an actin-based motive force through
internalin-dependent uptake of L. monocytogenes (2, 26). After escape from the
phagosome, a network of actin filaments and actin-binding proteins surrounds L.
monocytogenes (2, 26–28). The protein is distributed evenly across the cell and begins to
concentrate on one pole while more filaments are consistently growing toward the surface
(2). This creates a motive force that pushes L. monocytogenes through the host cytoplasm
at speeds of up to 1.5 μm/s (2). Polymerized actin structures are used to propel the
bacterium from the cytoplasm to the cell membrane, where it is jettisoned out of the host
cell while acquiring a portion of the host cell membrane before entering the next host cell
(2, 7, 12).
There are three components to ActA: the N-terminal, a central proline-rich repeat
region, and the c-terminal (2). When L. monocytogenes enters the host, the ActA protein
aids in its cellular uptake (2). The ActA N-terminal consists of positively charged
particles which, upon host cell entry, bind to the negatively charged heparin-sulfate (HS)
moiety (2). The HS moiety is part of HS proteoglycans (HSPG) found on most
mammalian cells (2). This binding process encourages uptake by host cells, either by
chemical signal or sufficient presentation of bacterial factors triggering phagocytosis (2).
Mutants lacking the N-terminal of the ActA protein could not polymerize actin, showing
that the component was necessary (29). The second component, the central proline-rich
repeat region, is a heavily proline-saturated area. When a mutant of this portion of the
protein was produced, the actin filaments were shorter in length and showed slower
movement (29). The third portion of ActA is the C-terminal, which includes a membrane

10

anchor but is not involved in actin polymerization (2, 28). When mutants lacking the Cterminal were created there was no significant impact on actin activity (29).
Another group of proteins called internalins aid in the entry of Listeria into the
host cell as well as in its infectious life cycle. L. monocytogenes can enter the host cell
both passively through phagocytosis and actively through the aid of ActA and internalins
(2, 4). InlA, encoded by the gene inlA, is a covalently bound surface protein with a Cterminal LPXTG motif, which reacts to adhesion E-cadherin proteins to allow cell entry
into epithelial cells via local cytoskeletal rearrangements (2, 4, 26). The inlB gene codes
for the InlB protein, which is non-covalently bound to the cell surface and helps facilitate
entry into host hepatocytes, fibroblasts, and epithelioid cells (2, 26). The final internalin
that is regulated by PrfA is InlC, which is coded by inlC and aids in the post-intestinal
stage of the L. monocytogenes life cycle (2).
The final virulence factor is hexose phosphate, which is a transporter molecule
(30). This protein is encoded by the hpt gene and is required for rapid bacterial growth in
the host cytosol (2, 30). The protein transports phosphorylated hexose sugars to aid in the
replication process. Mutants have shown a strong decrease in virulence capability (30).
The gene is completely controlled by the PrfA protein (30).
Upon host cell entry, PrfA acts as a transcriptional activator (1, 3, 5, 12). The
core ten genes are down-regulated during extracellular growth and are usually weakly
active until host infection (2). The PrfA dimer activates the virulence genes using the
palindromic promoter box, known as the “PrfA box” (7, 12, 25). The binding process of
PrfA to the PrfA box recruits required proteins for transcription. A co-factor binds to the
N-terminal beta-roll domain causing a conformational change that is allosterically
transmitted to the C-terminal helix-turn-helix motif (2). This conformational change
triggers the transcription of virulence genes (2). Usually at 30°C there is a 5’ UTR
(untranslated region) that blocks the ribosome binding site (2). At 37°C the secondary
structure melts to allow for PrfA translation (2).
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There are multiple PrfA boxes that are used to regulate non-virulence associated
homeostasis functions from about 145 genes (2). The virulence genes associated with the
prfA regulon can be found in relation to the life cycle in Figure 1. The majority of the
core ten virulence factors can be found close to one another on the chromosomal Listeria
pathogenicity island 1 (LIPI-1). The island is made up of inlA, inlB, inlC, hpt, plcA, hly,
mpl, actA, and plcB. Although mpl, actA, and plcB are part of the LIPI-1, they also make
up the lecithinase operon (2).

Figure 1. L. monocytogenes intracellular infection. Upon host cell entry [1] the bacterium is
taken into a phagosome, which it then escapes [2]. The bacteria begin to replicate [3] followed by
polymerization of actin comet tails [4]. The bacteria begin to take a portion of the host membrane
while entering another host cell [5], resulting in the double vacuole [7] . Source(s): Ireton K,
Rigano LA, Dowd GC. 2014 Role of host GTPases in infection by Listeria monocytogenes. Cell
Microbiol. 16:1311-1320.
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1.6 The splicing overlap extension PCR technique
There are many methods available for the manipulation of the genomic makeup of
bacterial species. One of the most common forms of DNA alterations is the polymerase
chain reaction (PCR). Splicing by overlap extension PCR is a method carried out by a
series of sequential PCRs designed to excise a gene of interest. Two sections of DNA that
flank the gene of interest are chosen for amplification (31, 32). The primers for those two
sequences are designed with overlapping extensions that facilitate subsequent splicing
(31, 32). Those two amplified products are then mixed together in a PCR that creates the
final spliced product (31, 32). That product can then be incorporated into a vector, such
as a plasmid, for transformation and gene knockout. Visual representation of this process
can be seen in Figure 2.

Figure 2. Diagram of SOEing primer orientation This diagram is a representation of the
orientation of primers used in the SOEing procedure. The SoeA, SoeB, SoeC, and SoeD primers bind
to regions flanking the gene of interest. The final product is a spliced amplicon of the two flanking
regions. Source(s): Kathrin Rychli , Caitriona M. Guinane , Karen Daly , Colin Hill and PDC. 2014.
Generation of Nonpolar Deletion Mutants in Listeria monocytogenes Using the “SOEing” Method.
Methods Mol. Biol. 1157:85–93.

The vector used in this study, pKSV7, was originally created for use in Bacillus
subtilis by Smith and Youngman (33). This vector is a hybrid between pUC18-ble and
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pBD95ts. It is a 6.9 kb shuttle vector that confers both ampicillin and chloramphenicol
resistance (31, 33). The pKSV7 plasmid was used to create a specific protocol of the
SOEing method for use in L. monocytogenes by Rychli et al. (31). After the sequential
PCR amplifications, the spliced product is integrated with the pKSV7 shuttle vector. The
plasmid is forced back into its supercoiled conformation and ligations are confirmed with
a transient transformation into E. coli DH5α cells (31). Electrocompetent L.
monocytogenes are made using the penicillin treatment method, which degrades the
Gram-positive cell wall to increase transformation efficiency (leaky-cells) (34). Cells
prepared with this method result in transformation efficiencies up to 4 x 106 /μg of DNA
(34). The confirmed ligation plasmids are then introduced into L. monocytogenes to
generate the desired mutant strains (31).
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CHAPTER 2
PROJECT DESIGN

2.1 Project aim one
The arginine deiminase pathway is a source of virulence capability for L.
monocytogenes, as previously mentioned. Due to evidence that the ADI pathway controls
a large portion of the L. monocytogenes acid survival mechanisms, this study attempted
to create a viable arginine deiminase pathway knockout. This knockout could also be
used in further studies exploring virulence capabilities of the species. This study
attempted to generate a Δarc strain using the splicing by overlap extension PCR
procedure to manipulate the L. monocytogenes genome.

2.2 Project aim two
As previously mentioned, L. monocytogenes is an infectious species due to
abundant virulence factors (4, 8, 12). The gene regulator PrfA controls ten crucial
virulence factors associated with L. monocytogenes (2, 7, 12, 25). A knockout mutant
lacking the virulence regulator PrfA could be useful for further studies. This study
attempted to generate a ΔprfA strain using the splicing by overlap extension PCR
procedure to manipulate the L. monocytogenes genome.
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CHAPTER 3
METHODS
3.1 Primer design
Primers were designed using the L. monocytogenes genome accession AJ002742.
The SoeA primer is a forward primer that binds upstream of the SoeB primer (31, 32).
SoeA also contains a 5’ enzyme restriction site that correlates with a pKSV7 restriction
site (31, 32). SoeB is a reverse primer that binds to a region flanking the gene targeted for
deletion (31, 32). SoeC is a forward primer that binds to a region flanking the gene
targeted for deletion, and has a 5’ region of ~20 base pairs (bp) that is the reverse
compliment of SoeB (31, 32). Lastly, SoeD is a reverse primer that binds downstream of
SoeC, and contains a 5’ enzyme restriction site that correlates with a pKSV7 restriction
site (31, 32). A version of SoeC was ordered without any of the alterations made and is
referred to as SoeC2. SoZ is a forward primer that binds upstream of SoeA and SoeE is a
reverse primer downstream of SoeD. When primers required a restriction site addition, a
leader sequence was added to ensure proper incorporation. All primers were edited to
optimal conditions by assessing GC concentration and ensuring GC clamps were present
when possible. A summary of guidelines for creating primers can be found in Table A.1
and specific primer design can be seen in Figure 2.
Primers for the prfA gene were designed using the L. monocytogenes genome
accession AJ002742. The SoeA primer includes a restriction enzyme site for BamHI, and
SoeD includes a restriction enzyme site for HindIII. Primers designed for the ADI gene
complex (arc) were designed using the PubMed accession AM412558. For this gene
SoeA had a restriction enzyme site for EcoRI and SoeD had one correlating to KpnI. The
final sequence for primers can be seen in Table 3.
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Table 3. SOEing primers for targeting the prfA Gene and the ADI gene
complex
Target

Primer

Sequence 5’-3’

Length

prfA

SoeA

AGAGATGGATCCGAGCAACCATCGGAACCAT

31

prfA

SoeB

CGTTCATGTCTCATCCCCCAATC

23

prfA

SoeC

TGGGGGATGAGACATGAACGATTAGCGAACAGGCTACCGC

40

prfA

SoeD

GTATCCAAGCTTAAATAGAGCCGAGCTTCCCG

32

prfA

SoeZ

TATTCCTACAAAAAAAGGGT

20

prfA

SoeE

TGCTTCTGTAAGTTCTTTAT

20

arc

SoeA

GATGCGAATTCTGTGCTTGCGCCATTTGTTT

31

arc

SoeB

TGTCTGCCGGAGCGAATAAAG

21

arc

SoeC

TTTATTCGCTCCGGCAGACATTCGGAAGTTTGATCCGCGTG

41

arc

SoeD

ATGTAGGTACCTACGACCTGTGGCACCGATA

31

arc

SoeZ

CCAACTGTGAACATTCTTTT

20

arc

SoeE

CAGCTCCCCATTTTTTTACA

20

Original primers were designed using the NCBI Primer-Blast program (35). Restriction enzyme
binding sites for BamHI were incorporated into prfA SoeA. Restriction sites for HindIII were added to
prfA SoeD. Restriction enzyme binding sites for EcoRI were incorporated into arc SoeA. Restriction
sites for KpnI were added to arc SoeD. Primers were altered to create optimal PCR conditions.

3.2 Stock L. monocytogenes
A KWIK-STIK™ (ATCC ® 19111™) of L. monocytogenes was plated on blood
agar plates (BAP) and incubated overnight at 37°C. After the incubation period, isolated
colonies were chosen from the BAP plate, and grown in overnight cultures of BHI broth.
500 μl of overnight culture was moved to microfuge tubes with 500 μl of 50% glycerol.
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All tubes were then stored at -80°C for stock. L. monocytogenes DNA was also extracted
from overnight cultures using the ChargeSwitch® DNA extraction kit.

3.3 Vent PCR for SoeAB and SoeCD
A 50 μL vent polymerase chain reaction was made with the following reagents
(31): 5 μL of 10X Thermopol reaction buffer (1x), 1 μL of 10mM dntp solution mix, 1.5
μL of each primer (20 μM), 0.5 μL of vent DNA polymerase (1 unit), 2 μL of 100mM
MgSo4 (6mM), 5 μL DNA template (determined by concentration), and PCR-grade H2O
up to 50 μL. Cycling conditions for the reaction can be seen in Table 4.

Table 4. Thermocycler conditions for vent polymerase chain
reactions

Initial denaturation

Annealing (30 cycles)

Final extension

Temperature (°C)

Time

95

5 minutes

95

30 seconds

55

30 seconds

72

1 minute

72

5 minutes

Vent polymerase chain reaction thermocycler conditions for SOEing reactions. Source(s): Kathrin Rychli,
Caitriona M. Guinane, Karen Daly, and Colin Hill. 2014. Generation of Nonpolar Deletion Mutants in
Listeria monocytogenes Using the “SOEing” Method. Methods Mol. Biol. 1157:85–93.
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Due to the complexity of the SoeC primer an extra vent PCR step was used. A
version of the SoeC primer (SoeC2) without the additional features was placed in the vent
PCR sample with the SoeD primer. That product was used as a DNA template, with the
SoeC and SoeD primers, to create the desired product containing restriction sites.
Products were verified with a 1.5% agarose gel (750 mg agarose and 50 mL of 1X TAE
buffer) and purified using ChargeSwitch® PCR purification kit.

3.4 Vent PCR for SoeAD
A 50μL vent polymerase chain reaction was made with the following reagents
(31): 5 μL of 10X Thermopol reaction buffer (1x), 1 μL of 10mM dntp solution mix, 1.5
μL of each primer (20 μM), 0.5 μL of vent DNA polymerase (1 unit), 2 μL of 100mM
MgSo4 (6mM), 5 μL SoeCD, 3 μL SoeAB, and PCR-grade H2O up to 50 μL. Cycling
conditions for the reaction can be seen in Table 4. Products were verified with a 1.5% gel
(750 mg agarose and 50 mL of 1X TAE buffer) and the sample was purified with
ChargeSwitch® PCR Purification kit.

3.5 Incorporating SoeAD into pKSV7
E. coli DH5α containing pKSV7 was grown in LB-amp50 overnight at 37°C with
consistent shaking and the plasmid was extracted using QIAprep spin miniprep kit. All
DNA concentration measurements were performed using the NanoDrop 2000 per
manufacturer protocol (36). Restriction digests were set up for the PrfA SoeAD product
and pKSV7 using HindIII and BamHI FastDigest enzymes from ThermoFisher. The
reaction for vector digestion included 1 μg of DNA, 2 μL of FastDigest buffer, 1 μL of
each enzyme, and H20 (reaction total of 30 μL). The reaction proceeded at 37°C for 20
minutes per manufacturer protocol. Heat inactivation was carried out at 80°C for 10
minutes. The PCR product digestion reagents were 0.2 μg of DNA, 2 μL of FastDigest
buffer, 1 μL of HindIII, 1 μL of BamHI, and H20 (reaction total of 30 μL). The reaction
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proceeded at 37°C for 25 minutes per manufacturer protocol. Heat inactivation was
carried out at 80°C for 10 minutes.
The arc SoeAD and pKSV7 were digested using EcoRI and KpnI FastDigest
enzymes. The pKSV7 digestion called for 1μg of DNA, 2 μL of FastDigest buffer, 1 μL
of each enzyme, and H20 (reaction total of 30 μL). The reaction was incubated for 20
minutes at 37°C and heat inactivated for 10 minutes at 80°C. The PCR product digestion
reagents were 0.2 μg of DNA, 2 μL of FastDigest buffer, 1 μL of EcoRI, 1 μL of KpnI,
and H20 (reaction total of 30 μL). The reaction proceeded at 37°C for 25 minutes per
manufacturer protocol. Heat inactivation was carried out at 80°C for 5 minutes. All DNA
measurements were done using the NanoDrop system. The samples were then purified
using the ChargeSwitch® PCR Purification kit.
For ligation the digested SoeAD and pKSV7 were mixed at three different molar
ratios over vector: 5:1, 3:1, and 1:1 (31). Each ligation included 2 μL of 10X ligation
buffer and 1 μL (5 Weiss U) of T4 DNA ligase. Each reaction incubated for one hour at
22°C. The ligation reactions were purified using the microdialysis technique where a MFMilliporeTM membrane filter was placed in a sterile petri dish containing 20 mL of sterile
H20 (31). The reaction was incubated at room temperature for 20 minutes, purifying the
sample via osmosis. DNA purity and concentrations were measured on the NanoDrop.

3.6 Transformation of E.coli
Electrocompetent DH5α E.coli (NEB #C2989K) were thawed on ice for 10
minutes. Cuvettes (1mm) were placed on ice while cells were prepared. 1 μL of the
ligated pKSV7 SoeAD product (10 pg/μL) was added to 25 μL of cells. The mixture was
carefully transferred to a chilled cuvette. The sides of the cuvette were wiped down with
a Kimwipe and the cuvette was tapped on the countertop twice before electroporating
using the BioRad electroporator set at 1.7 kV, 200 Ω, and 25 µF. 975 μL of pre-warmed
(37°C) SOC, a specialized recovery broth for E. coli, was immediately added to the
mixture and pipetted twice. The contents were then transferred to a 15 mL tube and
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rotated at 250 rpm for one hour. Unaltered pKSV7 was used as a control in conjunction
with every transformation. From all cultures 200 μL was plated on LB-amp50 overnight at
37°C.
Integration of SoeAD into the pKSV7 backbone was verified by two methods:
plasmid extraction followed by digestion or colony PCR. For the former method plasmids
were extracted from single colonies using the QIA spin mini-prep kit. The arc samples
were digested with EcoRI and KpnI. The prfA samples were digested with BamHI and
HindIII. The reaction for vector digestion included 1 μg of DNA, 2 μL of FastDigest
buffer, 1 μL of each enzyme appropriate to gene, and H20 (reaction total of 30 μL). The
reaction proceeded at 37°C for 20 minutes per manufacturer protocol and verified with a
1.5% gel. For colony PCR, single colonies were placed in 10 μL of 10% IGEPAL-G630
and heated at 95°C for 10 minutes. That reaction was then used as the DNA template in
the following PCR: 5 μL of 10X Thermopol reaction buffer (1x), 1 μL of 10mM dntp
solution mix, 1.5 μL of each primer (20 μM), 0.5 μL of vent DNA polymerase (1 unit), 2
μL of 100mM MgSo4 (6mM), 5 μL of DNA template, and PCR-grade H2O up to 50 μL.
Thermocycler settings for this reaction can be seen in Table 5. Products were verified on
a 1.5% gel and positive plasmid extracts were also frozen (-80°C) as stock for later use.
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Table 5. Thermocycler conditions for colony polymerase chain
reactions

Temperature (°C)

Time

94

3 minutes

94

30 seconds

50

30 seconds

72

1.5 minute

10

∞

Initial denaturation

Annealing (30 cycles)

Hold

Colony polymerase chain reaction thermocycler conditions. Source(s): Kathrin Rychli , Caitriona M.
Guinane , Karen Daly , Colin Hill and PDC. 2014. Generation of Nonpolar Deletion Mutants in Listeria
monocytogenes Using the “SOEing” Method. Methods Mol. Biol. 1157:85–93.

3.7 Electrocompetent L. monocytogenes
L. monocytogenes was grown in 5 mL of BHI overnight at 37°C with shaking.
Two mL of the overnight culture was added to 100 mL BHI and 0.5 M sucrose in a 500
mL flask (31, 34). The culture was grown at 300 rpm for 5-6 hours at 37°C until an
OD600 of 0.2 was reached (31, 34). Optical density measurements (OD600) were taken on
the NanoDrop 2000 using the cell culture software, per manufacturer protocol (36). 100
μL of 10mg/mL penicillin stock was added and the culture was incubated for 2 hours
under the same conditions (31, 34). Cells were centrifuged for 10 minutes at 8,700 x g
and the supernatant was removed (31, 34). The pellet was resuspended in 90 mL of 1mM
HEPES and 0.5 M sucrose (31, 34). Cells were centrifuged for 10 minutes at 8,700 x g
and the supernatant was removed (31, 34). The pellet was resuspended in 45 mL of 1mM
HEPES and 0.5 M sucrose (31, 34). Cells were centrifuged for 10 minutes at 8,700 x g
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and the supernatant was removed. 200 μL of 1mM HEPES and 0.5 M sucrose was added
to resuspend the pellet. Cells were frozen at -80°C. When transformed with puc19 (10
pg/μL) prepared electrocompetent L. monocytogenes reached transformation levels of 7 x
105 /μg of DNA.

3.8 Transformation of L. monocytogenes
For the electroporation reaction 4 μL of the plasmid was added to 50 μL of
electrocompetent cells. The cells were electroporated in a pre-chilled cuvette (2mm) at
the following parameters: 2 kV, 400 Ω, and 25 μF (31). 1mL of BHI-0.5M sucrose was
immediately added to the cells. The contents were then transferred to a 15 mL tube and
incubated at 30°C. A control of unaltered pKSV7 was used as a control in conjunction
with every transformation. The cells were plated on BHI-amp50 for 48 hours at 30°C.

3.9 Chromosomal integration
Three colonies displaying antibiotic resistance were selected from the
transformation plates. The colonies were inoculated in 10 ml BHI-cm10 broth and then
plated on BHI-cm10. Those cultures were incubated for 24 hours at 42°C. One mL of the
broth was moved to a fresh 9 mL of BHI-cm10, and again plated on BHI-cm10. The
cultures were incubated for 24 hours at 42°C. This process was repeated 3 more times.
Liquid cultures from the 5th passage were plated on BHI plates and incubated at 30°C for
24 hours. Three to five colonies were screened for chromosomal integration using colony
PCR with combinations of SoeZ, SoeE, SoeA, and SoeD. The colonies were also
inoculated into 10 mL of BHI and incubated at 30°C for 24 hours.
If no mutants were detected during colony PCR the passaging process continued
as follows: 1 mL of the overnight culture was moved to a fresh 9 mL of BHI and
incubated at 30°C for 24 hours in parallel with BHI plates. This process was repeated
until a mutant could be detected. Colony patching was repeated every 5th passage until
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chromosomal integration was detected. Single colonies were chosen and plated onto a
BHI plate and a BHI-cm10 plate, using a template. Colonies that did not show resistance
to chloramphenicol were extracted, amplified by colony PCR, and analyzed on a 1.5%
gel for mutant verification. The ΔprfA and Δarc colonies were frozen at -80°C in 50%
glycerol once integration was achieved.

3.10 Verification of construct integration
Colony PCR was used to confirm chromosomal integration of the plasmid into the
targeted gene of interest. Single colonies from chromosomal integration passages were
isolated for examination. Single colonies were placed in 10 μL of 10% IGEPAL-G630,
heated at 95°C for 10 minutes. That reaction was then used as the DNA template in the
following PCR: 5 μL of 10X Thermopol reaction buffer (1x), 1 μL of 10mM dntp
solution mix, 1.5 μL of each primer (20 μM), 0.5 μL of vent DNA polymerase (1 unit), 2
μL of 100mM MgSo4 (6mM), 5 μL of DNA template, and PCR-grade H2O up to 50 μL.
Thermocycler settings for this reaction can be seen in Table 5. Combinations of primers
SoeZ, SoeE, SoeA, and SoeD, which flank the gene of interest, were used for verification
(Table 3). Products were verified on a 1.5% gel and positive samples were also frozen (80°C) as stock for later use.
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CHAPTER 4
RESULTS
4.1 Vent PCR product for SoeAB and SoeCD
The purified vent PCR products for both genes of interest were verified
successfully by electrophoresis on a 1.5% agarose gel. The amplicon for the prfA gene
SoeAB product was ~ 256 bp and the SoeCD product was ~201 bp. For the arc gene the
SoeAB product was ~119 bp and the SoeCD was measured at ~417 bp. In order to get
SoeCD for the arc gene a Vent PCR amplification using a SoeC primer without
restriction sites had to be used (Primer C2). This product is referred to as SoeC2D. The
SoeC2D product showed an amplicon at ~384 bp and was purified then used as the DNA
template with primers SoeC and SoeD to create SoeCD. All gel readings were
appropriate to the amplification regions and were repeated with multiple trials to verify
results. The gel electrophoresis photos can be seen in Figure 3.

Figure 3. Gel electrophoresis: SoeAB and SoeCD. The first well on each gel is a 100 bp ladder. The
gel on the left shows vent PCR results for the prfA gene. Wells 2 and 3 show prfA SoeAB (~256 bp)
and wells 4 and 5 SoeCD (~201 bp). The gel image on the right shows results for the arc gene vent
PCR results. Well 2 shows arc SoeAB (~119 bp) and well 3 shows SoeCD (~ 417 bp).
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4.2 Vent PCR product for SoeAD
The purified vent PCR products for both genes of interest were verified
successfully with electrophoresis on a 1.5% agarose gel. The SoeAD product for the prfA
gene had an amplicon at ~447 bp, which was correct based on gene mapping. The SoeAD
product for the arc gene showed the expected amplicon at ~537 bp. The gel
electrophoresis photos can be seen in Figure 4.

Figure 4. Gel electrophoresis: SoeAD. The first well on both pictured gels is a 100 bp ladder. The gel on the
left shows vent PCR results for the prfA gene. Wells 2 and 3 show the SoeAD product at ~447 bp. The gel image
on the right shows results for both the prfA gene and the ADI pathway. Well 2 shows SoeAD for prfA and well 3
shows SoeAD for the ADI gene at ~537 bp.

4.3 Ligation and transformation into E. coli
The ligation product (pKSV7-AD) was electroporated into E. coli and grew on
overnight plates of LB-amp50. The ability to grow on this media shows successful uptake
of the pKSV7 plasmid containing ampicillin resistance. Colonies from the plates were
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selected for plasmid extraction using the QIAprep spin miniprep kit followed by
amplification of the SoeAD gene via PCR. The gel for prfA pKSV7-AD showed an
amplicon of ~440 bp released from the plasmid. The gel for the arc pKSV7-AD sample
showed an amplicon at ~520 bp. These results confirmed that the ligation product was
correctly assembled. The gel electrophoresis photos can be seen in Figure 5.

Figure 5. Gel electrophoresis: pKSV7-AD. The first well on each gel is a 100 bp ladder. The gel on the left
shows the positive prfA SoeAD insert at ~440 bp in well 4. This sample is derived from minipreped pKSV7
from transformed E. coli and amplified with PCR using SoeA and SoeD primers. The gel image on the right
shows colony PCR samples from pKSV7-AD ADI. The samples that show an amplicon at ~520 bp are
considered positive. The positive samples were wells 2,3,5,8, and 10. The other wells were negative for AD
inserts. Dim bands at the top, which are not addressed, are non-specific genomic DNA binding common in
colony PCR.

4.4 Transformation of L. monocytogenes
The pKSV7-SoeAD plasmid was electroporated into electrocompetent L.
monocytogenes by electroporation and the samples grew on overnight BHI-cm10 plates at
30°C. This display of chloramphenicol resistance showed the successful uptake of the
plasmid. Three colonies displaying resistance were moved to 42°C on BHI-cm10 plates.
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4.5 Chromosomal integration
Cultures of Δarc transformants grew in the presence of chloramphenicol at 42°C.
The pKSV7 plasmid, which confers chloramphenicol resistance, cannot remain
extrachromosomal at this temperature. The fact that cells survived on chloramphenicol
plates, at this temperature, signifies the plasmid was incorporated into the chromosomal
DNA. To see if the plasmid was incorporated into the targeted arc gene of the
chromosome, colony PCR was performed. The Δarc DNA was extracted from colonies
that were isolated from the 5th cell passage. The colony PCR samples were designed
using primers that flank the arc gene of interest. Wild type colony PCR samples were run
in parallel, as a negative control. The deletion target for the arc gene was ~1901 bp.
Colony PCR was performed on Δarc DNA samples with the primer pair SoeZ and SoeD,
as well as the primer pair SoeE and SoeA. All primers are shown in Table 3 and
experimental design methods are shown in Figure 2. The use of both sets of primers
allows examination of either side of the arc gene to check for pKSV7 integration.
The amplicon of a wild type colony, or an Δarc I colony with no chromosomal
integration, amplified with SoeZ and SoeD would be ~2925 bp. The Δarc colony DNA
amplified with SoeZ and SoeD showed an amplicon at ~2925 bp. The amplicon of a wild
type colony, or an Δarc colony with no chromosomal integration, amplified with SoeE
and SoeA would be about 2667 bp long. The Δarc colony DNA amplified with SoeE and
SoeA showed an amplicon at ~2667 bp. The resulting colony PCR samples were
consistent with the expected amplicon size of the arc gene with no pKSV7 integration.
This suggests that the construct did not integrate into the correct location on the
chromosome. The pKSV7 plasmid is untranslatable at high temperatures, such as 42°C.
The fact that the Δarc transformation cells were able to translate antibiotic resistance at
42°C indicates pKSV7 had incorporated into the L. monocytogenes chromosome. The
results of the Δarc colony PCR samples and the wild type negative controls can be seen
in the gel image found in Figure 6.
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Figure 6. Gel electrophoresis: chromosomal integration Δarc. Wells 1 and 2 contain a 1 kb and
100 bp ladder, respectively. Well 3 shows the wild type colony DNA was amplified with the SoeZ
and SoeD primer set at ~2925 bp, which is correct. Well 4 contains Δarc colony DNA amplified
with the same primers at ~2925 bp. No change between the wild type and Δarc sample was
observed. Well 5 shows wild type DNA was amplified with SoeA and SoeE at ~2667 bp, which is
the expected band size. Well 6 shows Δarc colony DNA amplified with the same primers at ~2667
bp. No change between the wild type and Δarc sample was observed.

Cultures of ΔprfA transformants grew in the presence of chloramphenicol at 42°C.
As previously mentioned, pKSV7 chloramphenicol resistance is untranslatable at 42°C as
an extrachromosomal unit. The fact that the cells survived on chloramphenicol plates, at
this temperature, signifies the plasmid was incorporated into the chromosomal DNA. In
order to analyze the samples for chromosomal integration of pKSV7, a colony PCR was
designed. The deletion target for the prfA gene was ~255 bp long. The ΔprfA DNA for
colony PCR was isolated from colonies during the 5th passage and wild type colony DNA
was used as a negative control. DNA samples were amplified with SoeZ and SoeD
primers, which flank the prfA deletion target. Primers are shown in Table 3 and
experimental design is shown in Figure 2. The expected amplicon for a wild type sample,
or a ΔprfA sample with no chromosomal integration, would be ~735 bp in length. Seven
samples of ΔprfA colony PCR showed a amplicon at ~480 bp, which is a decrease of
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~255 bp in comparison to the wild type strain. One ΔprfA colony PCR sample showed an
amplicon identical to the wild type strain, signifying a non-mutant sample. These results
can be seen in Figure 7. The knockout of the 255 bp region in the prfA gene was
successful and ΔprfA colonies were frozen down as stock.

Figure 7. Gel electrophoresis: chromosomal integration ΔprfA. Well 1 contains a 100 bp
ladder. Well 2 contains a wild type colony PCR sample amplified with the SoeZ and SoeD
primer set. The wild type sample matches the expected amplicon of ~735 bp. Wells 3 through 10
were ΔprfA samples amplified with the SoeZ and SoeD primer set showing an amplicon at ~480
bp. All colonies were positive for mutant strain except for well 5, which matched the wild type.
Dim bands in the background, which are not addressed, are non-specific genomic DNA binding
common in colony PCR.
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CHAPTER 5
DISCUSSION
L. monocytogenes is a virulent species due to many factors produced during the
host infection cycle (7, 16, 19). Listeria has the ability to survive and propagate
efficiently within a host (19). Many virulence factors are responsible for survival during
the host infection cycle. The arginine deiminase pathway helps regulate acidic
environments to which L. monocytogenes is exposed (6, 20). This pathway has the ability
to convert arginine to ammonia, ornithine, and ATP (6, 20). With the help of a
membrane-bound antiporter, the ornithine is transported out of the cell while the
ammonia is converted to ammonium, both of which help balance intracellular pH (6, 20).
ATP by-products can also be used with the F0F1-ATPase system to help maintain
homeostasis (6, 20).
The prfA gene, which codes for the PrfA protein, is considered to be a crucial
virulence regulator in L. monocytogenes (6, 16, 37). The prfA regulon is both an activator
and repressor of its own gene cluster (2, 19, 24). The PrfA protein has the ability to bind
to palindromic promoter boxes within the chromosome in order to recruit necessary
components for transcription (2, 19, 24). There are a total of 145 genes in the Listeria
chromosome regulated by PrfA; however, there are only ten associated with virulence
capabilities (2). The ten core genes subject to PrfA regulation are hly, mpl, actA, plcB,
plcA, prfA, inlA, inlB, inlC, and hpt (2, 4, 14, 19, 25). The PrfA protein is responsible for
regulating virulence expression at every stage of the L. monocytogenes infectious life
cycle.
L. monocytogenes is highly immunogenic and has the potential to be used in
vaccine production (2). Several studies have attempted to develop a killed vaccine with L.
monocytogenes (2). Killed vaccines are bacterial cells that have been inactivated by
chemical or physical reactions. This process has been known to destroy some bacterial
antigens but many species treated with this method still result in immunity (2). Some
diseases that have effective killed type vaccines include typhoid fever, cholera, plague,
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lyme disease, and pertussis (2). However, studies using L. monocytogenes for production
of a killed vaccine have been well documented and unsuccessful (2). There was minimal
resistance to listerosis in mouse models infected with high doses of heat killed L.
monocytogenes (2).
Live attenuated vaccines have a better chance of eliciting immune resistance to
Listeria infection. Attenuated Listeria cells have less virulence factors for infection while
still maintaining the ability to replicate in the host. This confers immunity to listerosis at
relatively low doses. Listeria infects antigen-presenting cells, monocytes, macrophages,
and dendritic cells (2). Listeria bacterial antigens are presented via the MHC class I
pathway to cytotoxic T- lymphocytes (CD8+) (2). Antigens are also presented via the
MHC class II pathway to T-lymphocyte helper 1 cells (CD4+) (2). The ability of L.
monocytogenes to interact with both MHC classes increases the efficiency of the live
vaccine.
Another potential use for attenuated Listeria could be a Listeria-based cancer
vaccine. Anti-cancer vaccines use the host body to fight off disease. Transforming
attenuated L. monocytogenes with cancer antigen genes can induce targeted self-reactive
T-cells (2). Attenuated Listeria, containing cancer antigen genes, are taken up and
degraded by phagocytic cells (13). The antigens would be presented on phagocytic cell
surfaces via the Major Histocompatibility Complexes I and II (2). Cytotoxic Tlymphocytes and T-lymphocyte helper 1 cells would react with the cancer antigens and
retarget the host immune system components. CD8+ and CD4+ T-cells have both been
found to have highly increased levels upon interaction with L. monocytogenes (2). This
fact makes the species a good candidate for immunotherapy for cancer patients. This
method is a relatively new approach to cancer and has the potential to be a much less
debilitating form of treatment for patients.
This study aimed to create a spliced arc gene (ADI pathway) mutant using the
splicing by overlap extension PCR procedure. The production of SoeAB and SoeCD
products for the arc gene were successful with amplicons at ~119 bp and ~417 bp,
respectively. Those products were successfully spliced to create the arc SoeAD PCR
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product with an amplicon at ~537 bp. The arc SoeAD insert was incorporated into
pKSV7 via digestion and ligation. The arc SoeAD insert was effectively verified after
transformation into E. coli. The arc pKSV7-AD plasmid was successfully introduced to
the L. monocytogenes strain via transformation. The pKSV7, which confers
chloramphenicol resistance, cannot be maintained as an extrachromosomal unit at 42°C.
The fact that the cells grew in the presence of chloramphenicol at this temperature
signifies that pKSV7 was incorporated into the chromosome.
The colony PCR results, however, showed no change compared to the wild type
strain. The wild type DNA amplified with primers SoeZ and SoeD are expected to
produce an amplicon at ~2925 bp. If pKSV7 were incorporated into the chromosomal
DNA sample, at the gene of interest, and the Δarc sample would be expected to yield an
amplicon at ~9825 bp. If pKSV7 had left the chromosome with the arc deletion target, a
mutant would yield an amplicon at ~1024 bp. The wild type DNA amplified with the
SoeA and SoeE primers are expected to produce an amplicon at ~2667 bp. The pKSV7
integrated with the targeted arc gene would yield an amplicon of ~9567 bp while a
successful mutant would produce an amplicon at ~ 766 bp. The Δarc colony PCR
amplification was identical to the negative control wild type amplification. This data
signifies the plasmid successfully incorporated into the chromosome; however, it was not
incorporated into the arc gene deletion target.
This resulted in an unsuccessful attempted Δarc mutant. The failure of the arc
pKSV7-AD to incorporate into the arc gene deletion target is likely due to an inefficient
SoeAD product. Small mutations in the SoeAD insert sequence could have been
introduced during the sequential PCR amplifications. This would cause correct amplicon
bands on gel verification but would not be specific for incorporation into the gene of
interest. The project data can still be helpful to further studies by provide an example of
potential errors in the procedure, which could be used to make the protocol more
efficient.
The second goal of this study was to create a spliced prfA gene mutant using the
splicing by overlap extension PCR procedure. The vent PCR amplification of SoeAB and
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SoeCD produced a correct amplicon at ~256 bp and ~201 bp, respectively. Those
products were successfully spliced to create the prfA SoeAD PCR product with an
amplicon at ~447 bp. The prfA AD product was incorporated into the pKSV7 backbone
via digestion and ligation. The prfA pKSV7-AD vector was verified to be correct after
transformation into E. coli. The prfA pKSV7-AD vector was successfully introduced to L.
monocytogenes and transformants grew in the presence of chloramphenicol at 42°C. The
fact that the L. monocytogenes samples were able to translate chloramphenicol resistance
at this temperature signified that the prfA pKSV7-AD was incorporated into the
chromosome.
Colony PCR using primers designed to flank the prfA gene deletion target was
used to verify chromosomal integration. The L. monocytogenes wild type DNA amplified
with primers SoeZ and SoeD would produce an amplicon at ~ 735 bp. If prfA pKSV7-AD
were still present in the chromosome, at the gene of interest, the ΔprfA sample would
produce an amplicon at ~7635 bp. If prfA pKSV7-AD had left the chromosome, with the
gene of interest, a mutant would yield an amplicon at ~480 bp. The colony PCR ΔprfA
reactions showed a decrease of ~255 bp in comparison to the wild type strain at ~ 735 bp.
The colony PCR of ΔprfA samples corresponded directly with expected results for a
mutant strain containing a spliced prfA gene. These results signify the plasmid left the
host chromosome with the gene of interest. The ΔprfA strain was isolated and will be
useful in further studies on this pathogen.
These further studies could to examine the change in virulence capability of the
wild type strain in comparison with successful mutant strains. This property could be
assessed using tissue culture assays that monitor infection and survival rates. This
comparative analysis would reveal how the loss of virulence factors affects the ability of
L. monocytogenes to propagate in vitro. Due to thermo-activated virulence up-regulation,
a study could also be designed to specifically investigate the differences in mutant strains
in vitro versus in vivo in murine models, as compared to wild type L. monocytogenes.
Comparing fatality and infection rates post-infection of each group could reveal effects of
mutations on virulence.
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APPENDICES

A1

APPENDIX A: SUPPLEMENTAL TABLES

A2

Primer Design Guidelines

Primer
SoeA

SoeB

SoeC

SoeD

SoeZ
SoeE

Location

Requirements

Forward primer
Binds upstream of
SoeB
Reverse primer
Binds to a region
flanking the gene
targeted for deletion
Forward primer
Binds to a region
flanking the gene
targeted for deletion

Contains a 5’
enzyme restriction
site

Reverse primer
Downstream of SoeC
Forward primer
Binds upstream of
SoeA
Reverse primer
Downstream of SoeD

N/A
Contains a 5’ region
of ~20 bp that is the
reverse compliment
of SoeB
Contains a 5’
enzyme restriction
site
N/A
N/A

Table A.1. Primers used in the SOEing method, use a method of overlap extension to incorporate the gene
of interest into the vector of choice for gene knockout. Source(s): Kathrin Rychli , Caitriona M. Guinane ,
Karen Daly , Colin Hill and PDC. 2014. Generation of Nonpolar Deletion Mutants in Listeria
monocytogenes Using the “SOEing” Method. Methods Mol. Biol. 1157:85–93.
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